More Chemotherapy Does Not Obviate the Need for Radiation Therapy (RT): Treatment for Early-Stage Favorable Hodgkin Lymphoma According to the HD10 Trial Compared With Chemotherapy Alone

被引：1
|
作者：
Pinnix, C. C. [1 ]
Abou Yehia, Z. [1 ]
Smith, G. L. [1 ]
Milgrom, S. A. [1 ]
Ho, J. C. [1 ]
Reddy, J. [1 ]
Gunther, J. R. [2 ]
Akhtari, M. [1 ]
Osborne, E. M. [1 ]
Medeiros, L. J. [1 ]
Fanale, M. [1 ]
Dabaja, B. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Div Radiat Oncol, Houston, TX 77030 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2016.06.1858
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3203
引用
收藏
页码：E489 / E490
页数：2
相关论文
共 50 条
  • [21] Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix
    Peters, WA
    Liu, PY
    Barrett, RJ
    Stock, RJ
    Monk, BJ
    Berek, JS
    Souhami, L
    Grigsby, P
    Gordon, W
    Alberts, DS
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (08) : 1606 - 1613
  • [22] PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 by the GHSG
    Eich, H. T.
    Baues, C.
    Fuchs, M.
    Kobe, C.
    Greil, R.
    Sasse, S.
    Zijlstra, J. M.
    Lohri, A.
    Rosenwald, A.
    Tresckow, B. V.
    Diehl, V.
    Kuhnert, G.
    Dietlein, M.
    Borchmann, P.
    Engert, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S1 - S1
  • [23] Does a negative post-therapy PET obviate the need for any further follow-up imaging in patients with nonbulky early-stage Hodgkin's lymphoma (HL)?
    Gallamini, A.
    Biggi, A.
    Chauvie, S.
    Bianchi, A.
    Conti, S.
    Fiore, F.
    Sorasio, R.
    Vose, J.
    Thomas, D. L.
    Juweid, M. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 By the German Hodgkin Study Group
    Fuchs, Michael
    Goergen, Helen
    Kobe, Carsten
    Eich, Hans
    Baues, Christian
    Greil, Richard
    Sasse, Stephanie
    Zijlstra, Josee M.
    Lohri, Andreas
    Rosenwald, Andreas
    von Tresckow, Bastian
    Diehl, Volker
    Kuhnert, Georg
    Dietlein, Markus
    Borchmann, Peter
    Engert, Andreas
    BLOOD, 2018, 132
  • [25] A prospective trial of radiation alone vs combination chemotherapy alone for early-stage Hodgkin's disease: Implications of 25-year follow-up to current combined modality therapy.
    Longo, Dan L.
    Glatstein, Eli
    Duffey, Patricia L.
    Young, Robert C.
    Fiem, Shelby
    Jaffe, Elaine S.
    Camphausen, Kevin
    Wilson, Wyndham
    DeVita, Vincent T.
    BLOOD, 2006, 108 (11) : 33A - 33A
  • [26] Radiation therapy and chemotherapy in the treatment of head and neck extranodal non-Hodgkin's lymphoma in early stage with a high grade of malignancy
    Donato, V
    Iacari, V
    Zurlo, A
    Nappa, M
    Martelli, M
    Banelli, E
    Enrici, RM
    Biagini, C
    ANTICANCER RESEARCH, 1998, 18 (1B) : 547 - 554
  • [27] Recent interim analysis of the HD11 trial of the GHSG: Intensification of chemotherapy and reduction of radiation dose in early unfavorable stage Hodgkin's lymphoma.
    Diehl, V
    Brillant, C
    Engert, A
    Mueller, RP
    Eich, HT
    Mueller-Hermelink, K
    Herrmann, R
    Markova, J
    Ho, A
    Hiddemann, W
    Doerken, B
    Greil, R
    Josting, A
    Pfistner, B
    BLOOD, 2005, 106 (11) : 240A - 241A
  • [28] Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group
    Fuchs, Michael
    Goergen, Helen
    Kobe, Carsten
    Kuhnert, Georg
    Lohri, Andreas
    Greil, Richard
    Sasse, Stephanie
    Topp, Max S.
    Schaefer, Erhardt
    Hertenstein, Bernd
    Soekler, Martin
    Vogelhuber, Martin
    Zijlstra, Josee M.
    Keller, Ulrich Bernd
    Krause, Stefan W.
    Wilhelm, Martin
    Maschmeyer, Georg
    Thiemer, Julia
    Duehrsen, Ulrich
    Meissner, Julia
    Viardot, Andreas
    Eich, Hans
    Baues, Christian
    Diehl, Volker
    Rosenwald, Andreas
    von Tresckow, Bastian
    Dietlein, Markus
    Borchmann, Peter
    Engert, Andreas
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (31) : 2835 - +
  • [29] Early-stage Hodgkin lymphoma outcomes after combined modality therapy according to the post-chemotherapy 5-point score: can residual pet-positive disease be cured with radiotherapy alone?
    Milgrom, Sarah A.
    Pinnix, Chelsea C.
    Chuang, Hubert
    Oki, Yasuhiro
    Akhtari, Mani
    Mawlawi, Osama
    Garg, Naveen
    Gunther, Jillian R.
    Reddy, Jay P.
    Smith, Grace L.
    Rohren, Eric
    Hagemeister, Frederick B.
    Lee, Hun J.
    Fayad, Luis E.
    Dong, Wenli
    Osborne, Eleanor M.
    Abou Yehia, Zeinab
    Fanale, Michelle
    Dabaja, Bouthaina S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 179 (03) : 488 - 496
  • [30] Treatment Outcomes and Prognostic Factors of Chemotherapy Combined With Radiation Therapy for Patients With Early-Stage Extranodal Natural Killer/T-Cell Lymphoma
    Wang, Shu-Bei
    Chen, Jia-Yi
    Zhao, Wei-Li
    Xu, Cheng
    Cao, Wei-Guo
    Han, Yi-Min
    Cheng, Shu
    Xu, Peng-Peng
    Zhong, Hui-Juan
    Cai, Gang
    ADVANCES IN RADIATION ONCOLOGY, 2024, 9 (12)
12345